BioCentury
ARTICLE | Financial News

Tvax Biomedical proposes IPO

November 14, 2011 8:00 AM UTC

Tvax Biomedical Inc., Lenexa, Kan. Business: Cancer, Infectious Date announced: 11/7/11 Type: IPO To be raised: Up to $40 million Shares: TBD Price: TBD Underwriters: Roth Capital Partners; Cantor Fit...